Whalegun
Home

Ra Capital Management reported a 9.9% stake in SAB Biotherapeutics SABS · 5,166,424 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
9.9%
Last report
9.9% · filed 25/10/03
Shares held
5,166,424 sh
Class
Common Stock, $0.0001 par value per share
Stock
SAB Biotherapeutics SABS
Holder
Ra Capital Management
Event date
26/03/09
Filed
26/03/11

9.9% stake · +0.0pp from the last report

Stake
9.9%
Last report
9.9%
Since last report
+0.0pp

SAB Biotherapeutics trades, last 26 weeks

What else happened in SAB Biotherapeutics around then

Filed or reported within 30 days of the trade day · 02/07~04/08

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeSionna Therapeutics

    14.3% stake

    Filed 09/21

  • Ra Capital Management

    5% stakeTyra Biosciences

    19.9% stake

    Filed 09/17

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03

  • Ra Capital Management

    5% stakeLatigo Biotherapeutics

    8.4% stake

    Filed 08/17